Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review

This publication has 42 references indexed in Scilit:

• Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use
  Journal of Clinical Oncology, 2003
• The value of [18F]fluoro-2-deoxy-?-glucose positron emission tomography in the selection of patients with stage IIIA-N2 non-small cell lung cancer for combined modality treatment
  Lung Cancer, 2003
• Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review
  The Lancet Oncology, 2001
• Ten year experience with induction therapy in locally advanced non-small cell lung cancer (NSCLC): is clinical re-staging predictive of pathological staging?
  European Journal of Cardio-Thoracic Surgery, 2001
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Stellenwert der Positronen-Emissions-Tomographie mit 18-Fluor-Desoxyglukose (FDG-PET) in der Rezidivdiagnostik des Bronchialkarzinoms
  Pneumologie, 2000
• Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer
  European Respiratory Journal, 1999
• Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
  European Journal Of Cancer, 1999
• Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)
  The Journal of Thoracic and Cardiovascular Surgery, 1995
• The Will Rogers Phenomenon
  New England Journal of Medicine, 1985